SCHEMBL3083318

SCHEMBL3083318

CN1CCC(Oc2ccccc2Cl)c2ccc(N3C=CC=CC3)cc2C1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.37
SSTR4 P31391 4/20 0.33
SSTR1 P30872 2/20 0.33
HTR2C P28335 7/20 0.33
HTR2A P28223 5/20 0.33
HTR2B P41595 5/20 0.33
SLC6A4 P31645 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
ESR2 Q92731 1/20 0.32
DRD2 P14416 1/20 0.31
DRD1 P21728 1/20 0.31
KCNH2 Q12809 2/20 0.31
CYP2D6 P10635 1/20 0.31
SLC9A3 P48764 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3073945 0.89 SSTR4 (0.34) SSTR4HTR2CSLC6A4MAPTESR2
SCHEMBL3094904 0.85 MCHR1 (0.38) MCHR1SLC6A4HRH3
SCHEMBL3081797 0.82 ESR1 (0.35) MCHR1SSTR4HTR2CHTR2AHTR2B
SCHEMBL3476357 0.78 SLC6A4 (0.41) MCHR1SSTR4SSTR1SLC6A4HRH3
SCHEMBL3476079 0.76 SLC6A2 (0.40) MCHR1HTR2CSLC6A4GAAMAPT
SCHEMBL3074623 0.74 SSTR4 (0.37) MCHR1SSTR4SSTR1HTR2CHTR2A
SCHEMBL3079877 0.73 SLC6A2 (0.45) SSTR4SSTR1HTR2CHTR2AHTR2B
SCHEMBL3096061 0.73 GSK3B (0.43) MCHR1SSTR4SSTR1SLC6A4DRD2
SCHEMBL3078965 0.72 ROCK2 (0.43)
SCHEMBL3081733 0.72 HTR2C (0.40) HTR2CHTR2ASLC6A4HRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146720-A1 ARYLOXY-AND HETEROARYLOXY-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR Technology, Inc. (US) 2010-01-27 EP disclosed
WO-2008141082-A1 ARYLOXY-AND HETEROARYLOXY-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR TECHNOLOGY, INC. (US) 2008-11-20 WO disclosed